Top Markets
Coin of the day
Enveric Biosciences, Inc. Enveric Biosciences, Inc.

Enveric Biosciences, Inc.

ENVB
Rang in Aktien #38575
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse... Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application. Rounding out their portfolio is EV101, a novel combination therapy integrating cannabinoids with chemotherapy. This innovative company is based in Naples, Florida.
Aktienkurs
$1.48
Marktkapitalisierung
$883.58K
Veränderung (1 Tag)
-1.99%
Veränderung (1 Jahr)
-88.89%
Land
US
Handel Enveric Biosciences, Inc. (ENVB)

Kategorie

Kursverlauf für Enveric Biosciences, Inc. (ENVB)
Höchster Schlusskurs: $1.53 am 2026-08-01

Niedrigster Schlusskurs: $4.75M am 2005-12-01
Kursverlauf der Aktie von Enveric Biosciences, Inc. von 2005 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -15.21%
2025 -91.07%
2024 -76.28%
2023 -38.51%
2022 -95.86%
2021 -83.62%
2020 -22.41%
2019 -58.83%
2018 -91.51%
2017 -49.55%
2016 -1.21%
2015 416.23%
2014 5.31%
2013 356.80%
2012 -76.68%
2011 39.62%
2010 43.94%
2009 -80.84%
2008 -55.69%
2007 72.79%
2006 -43.88%
2005 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$507.41 30.01%
US
$848.17 30.00%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE